ANEB
Anebulo Pharmaceuticals
ANEB
ANEB
Delisted
ANEB was delisted on the 27th of February, 2026.
13 hedge funds and large institutions have $20M invested in Anebulo Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
13% less funds holding
Funds holding: 15 → 13 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Holders
13
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$72.4K | |
| 2 | +$1.02K | |
| 3 | +$165 | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$33 |
| 5 |
JP Morgan Chase
New York
|
+$3 |
Top Sellers
| 1 | -$72.5K | |
| 2 | -$4.67K | |
| 3 | -$731 | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$413 |
| 5 |
Wells Fargo
San Francisco,
California
|
-$178 |